Clinical trial
Myocardial Perfusion and Fibrosis in Cancer Survivors
NCT03191461 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Myocardial Perfusion and Fibrosis in Cancer Survivors
- Lead sponsor
- Virginia Commonwealth University
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 13, 2017
- Completion date
- April 11, 2024
- Enrollment
- 7 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
chemotherapeutic toxicity, myocardial fibrosis, myocardial injury